Refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: A case report.

Kojima, Minoru; Ogiya, Daisuke; Ichiki, Akifumi; Hara, Ryujiro; Amaki, Jun; Kawai, Hidetsugu; Numata, Hiroki; Sato, Ai; Miyamoto, Mitsuki; Suzuki, Rikio; Machida, Shinichiro; Matsushita, Hiromichi; Ogawa, Yoshiaki; Kawada, Hiroshi; Ando, Kiyoshi

Kojima, Minoru; Ogiya, Daisuke; Ichiki, Akifumi; Hara, Ryujiro; Amaki, Jun; Kawai, Hidetsugu; Numata, Hiroki; Sato, Ai; Miyamoto, Mitsuki; Suzuki, Rikio; Machida, Shinichiro; Matsushita, Hiromichi; Ogawa, Yoshiaki; Kawada, Hiroshi; Ando, Kiyoshi.

Afiliación

Kojima M; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan; Department of Hematology, Ebina General Hospital, Japan.
Ogiya D; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan.
Ichiki A; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan.
Hara R; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan.
Amaki J; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan; Department of Hematology, Ebina General Hospital, Japan.
Kawai H; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan.
Numata H; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan.
Sato A; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan.
Miyamoto M; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan.
Suzuki R; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan; Division of Internal Medicine, Hadano Red Cross Hospital, Japan.
Machida S; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan.
Matsushita H; Department of laboratory Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan.
Ogawa Y; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan.
Kawada H; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan.
Ando K; Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan.

Leuk Res Rep ; 5: 11-3, 2016.

Article en En | MEDLINE | ID: mdl-27144119

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Leuk Res Rep Año: 2016 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google